/
/
/

Dipna Pharmachem Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Mar 2026Mar 2025
₹2 Cr₹16 Cr
₹2 Cr₹16 Cr
₹2 Cr₹15 Cr
₹46 L₹1 Cr
₹23 L₹60 L
₹22 L₹68 L
₹18 L₹50 L

Share Price Live Stats

Open (₹)4.09
Volume (₹)21,000.00
High (₹)4.16
Upper Circuit4.45
Low (₹)4.07
Lower Circuit3.65
Prev Close4.05
52W High (₹)21.35
Price4.07
52W Low (₹)3.89

Share Market Cap & Key Ratios Overview

M.Cap (₹)10.65 Cr
Div. Yield (%)0.00
PE Ratio4.05
Debt to Equity0.45
Price to Book0.89
Book Value16.01
EPS (TTM)1.00
Face Value10.00
ROE (%)2.56

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
ADANIENT-ANSE
CPPLUS-ANSE
AEGISLOG-ANSE
PREMIERENE-ANSE
REDINGTON-ANSE
HONASA-ANSE
LLOYDSENT-ANSE
CELLO-ANSE
JSLL-ANSE
SREEL-TNSE
DPL-MNSE
LTP
1W Low
1W High
Market cap (₹)
2699.7+66.6 (2.53%)
2611
2734
3,65,505Cr
4062.5-123.55 (-2.95%)
4014
4619.10
50,379Cr
1377.05-11.05 (-0.80%)
1350.50
1509.90
49,482Cr
902.45+7.45 (0.83%)
884.80
930.90
41,337Cr
385.15+5.05 (1.33%)
380
411.45
30,653Cr
451.45-17.3 (-3.69%)
445.40
481
14,608Cr
71.51-2.33 (-3.16%)
69.25
74.73
10,762Cr
374.85+9.55 (2.61%)
359.05
385.40
8,198Cr
387.5+2.2 (0.57%)
378.70
406
4,831Cr
275.5+2.85 (1.05%)
275.50
284
642Cr
4.07+0.12 (3.04%)
4.02
4.54
11Cr
Empty box

No content available